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Abstract The aim of this study was to analyze the
mechanisms of lumen enlargement in bifurcation lesions,
as assessed by intravascular ultrasound (IVUS), after per-
cutaneous treatment with classic provisional ‘‘T’’ stenting
with conventional drug-eluting stents (DES) versus bifur-
cation dedicated BiOSS (Balton, Warsaw, Poland) stent.
In this prospective study between Jan and Dec/11, 32
patients with single de novo coronary bifurcation lesions
suitable for treatment with BiOSS stents were randomized
(1:1). IVUS method included pre- and post-procedure
analysis in the parent vessel. Vessel, lumen and plaque
cross-sectional areas were determined at the target lesion
[minimum lumen area (MLA) site], proximal limb, distal
limb, and ‘‘window’’—defined as the segment between the
carina (flow divider) and the vessel wall at the level of the
side branch inflow. All lesions were treated with provi-
sional approach and only 1 case in BiOSS group had a stent
implanted in the side branch. Angiographic and IVUS
results including MLA at the target site and proximal/distal
references were similar. However, mean window length—
largest diameter within the window, was similar at base-
line, but BiOSS measured significantly longer at postpro-
cedure (2.21 ± 0.37 vs. 1.76 ± 0.52 mm, p = 0.01). In
addition, the magnitude of changes in vessel (27 ± 24 %
vs. 9 ± 10 %, p = 0.01) and plaque (2 ± 26 % vs.
-2 ± 26 %, p = 0.02) areas at the window were signifi-
cantly different for DES versus BiOSS groups, respec-
tively. The contribution of vessel extension for lumen
enlargement represented 54 versus 43 %, 130 versus 46 %,
98 versus 80 % and 51 versus 19 % of the result achieved
at the proximal limb, window, distal limb and MLA sites
for DES versus BiOSS, respectively; as for plaque re-dis-
tribution, results were 36 versus 57 %, -30 versus 54 %, 2
versus 20 %, and 49 versus 81 %, at the proximal limb,
window, distal limb and MLA sites, respectively. These
results suggest different mechanisms of lumen enlargement
comparing conventional DES versus BiOSS dedicated
bifurcation stent, which can impact side branch compro-
mise during procedure.
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Introduction
Recently published data on BiOSS Expert stent (Balton,
Warsaw, Poland) Registry showed that this bifurcation
dedicated device is very promising both for the operator as
user‘s friendly and for patients in regard of good immediate
and short-term clinical results [1]. This balloon-expandable
stent is made of 316L stainless steel and has unique con-
struction that consists of two parts with different diameters
connected with two struts. Its delivery system is based on a
bottle shaped balloon (Bottle, Balton, Poland) which
restores ‘‘proximal’’ main vessel and ‘‘distal’’ main branch
sizes without the need of an additional dilatation called
kissing ballooning [1]. As it was proven, the construction
of the BiOSS stent prevents from carina displacement—the
basic mechanism of side branch compromise during
bifurcation percutaneous coronary intervention [2]. This
step-up mid zone of the BiOSS stent created by two rela-
tively short connecting struts (mean length 1.2 mm) on the
one hand should secure good access to SB and stent‘s
flexibility, but on the other may be its ‘‘weak point’’ due to
lower radial forces and a low dose of an antiproliferative
substance. Theoretically, this part of the BiOSS stent may
be responsible for not so optimal results achieved imme-
diately after its implantation and during late follow-up.
The aim of the study was to analyze the mechanisms of
lumen enlargement after the coronary bifurcation dedicated
stent BiOSS versus the classical stent implantation according
to the provisional ‘‘T’’ stenting strategy, as determined by
intravascular ultrasound (IVUS) measurements.
Methods
Study population
Between January 2011 and December 2011, a total of 32
patients with stable coronary artery disease were consec-
utively enrolled and randomized in this prospective study
at a single center. The main inclusion criteria were pres-
ence of de novo coronary bifurcation lesion suitable for
treatment with the BiOSS device, serum creatinine level
below 2.0 mg/dL and the ability to take dual antiplatelet
therapy for 12 months. The main exclusion criteria were
ST-elevation acute coronary syndrome and the lack of
signed informed consent. Overall, patients had to be
qualified by the institution’s Heart Team for percutaneous
revascularization. However due to BiOSS stent size
availability in that time (maximal diameter 3.75 mm)
patients with so called big left main stems (proximal ref-
erence diameter C4.0 mm by QCA) were excluded. The
studied population was divided in two groups, both con-
sisting of 16 patients (randomization 1:1), according to the
device and strategy used for bifurcation treatment: drug-
eluting stents (DES) with PTS strategy (DES group) versus
BiOSS Expert dedicated DES (BiOSS group).
The study was conducted according to the principles of
the Declaration of Helsinki, and the protocol was approved
by the institutional review board. Written informed consent
was obtained from all patients before procedure.
Procedure
All procedures were performed in a standard way via the
radial or femoral access using guiding catheters of 6- and
7-Fr. in diameter. A single stent implantation in the main
vessel ? main branch across side branch was the default
strategy in all patients. A stent in side branch was
implanted only in case of ostial residual stenosis greater
than 70 % after balloon dilatation and/or significant flow
impairment after main vessel ? main branch stenting and/
or flow limiting dissection. The recommended strategy was
to choose the stent diameter according to distal reference
diameter (localized in main branch). Overall, the following
consecutive steps for the implantation protocol were
considered:
1. wiring of both branches;
2. main vessel predilatation and/or side branch predila-
tation according to the operator’s decision;
3. stent implantation—balloon inflation at 10–12 atm for
at least 20 s;
4. stent postdilatation with Bottle balloon at operator’s
discretion in BiOSS group, and with non-compliant
balloon in DES group (separately for main vessel and
main branch);
5. side branch postdilatation if presence of side branch
ostial stenosis [70 %;
6. final kissing balloon inflation at operator’s discretion.
In regard to the antithrombotic therapy, all patients were
pre-treated with conventional loading doses of aspirin and
clopidogrel (300–600 mg) at least 48 h before procedure,
followed by aspirin 150 mg/day and clopidogrel 75 mg/
day. Use of glycoprotein IIb/IIIa inhibitors was left to the
operator’s discretion. At postprocedure, dual antiplatelet
therapy including aspirin 75–150 mg/day plus clopidogrel
75 mg/day was prescribed for 12 months. After insertion of
the arterial sheath, each patient received unfractionated
heparin (70–100 IU/kg); additional bolus was given to
maintain an activated clotting time [200 s.
Patients were clinically evaluated (medical evolution,
physical examination, ECG) at 30 days, 6, 9 and
12 months. Angiographic re-evaluation was planned at
12 month.
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Angiographic analysis
All coronary angiograms were recorded after an intracor-
onary administration of 200 lg of nitroglycerin. Two
orthogonal views were chosen to visualize the target lesion.
A quantitative angiographic analysis was performed using
commercially available software (QCA-CMS version 5.0,
Medis, Leiden, the Netherlands). Catheter calibration was
used in all cases. The main vessel (arterial segment before
side branch take-off), the main branch (arterial segment
beyond the side branch ostium), and the side branch were
individually analyzed [3]. Thus, the following parameters
were determined: reference vessel diameter, minimal
lumen diameter (MLD) and percent diameter stenosis for
the main vessel, main branch, and side branch before and
after stent implantation. All reference diameters (user-
defined) were measured within 5 mm from the end of the
angiographically visible plaque or stenosis in all 3 seg-
ments of the bifurcation. Percent diameter stenosis (for
each segment) was calculated by the following formula:
diameter stenosis = [1 - (MLD/reference vessel diame-
ter)] 9 100. Measurement of a angle (carina angle) was
performed as previously described [4, 5]. Angiographic
success was defined by main vessel and main branch
diameter stenosis less than 20 % and side branch ostial
stenosis less than 70 % without significant dissection and
flow impairment [6].
Intravascular ultrasound
After baseline coronary angiography, an IVUS catheter
(Eagle Eye Gold, Volcano Corporation, Rancho Cordova,
CA, USA) was advanced distally to the bifurcation to be
stented. Pullback was performed at the speed of 0.5 mm/s.
until the guiding catheter was reached. Plaques were
characterized by their appearance on IVUS images (soft,
hard, mixed) according to widely accepted definitions [7].
External elastic membrane (EEM) was taken as a border of
vessel’s total cross-sectional area (CSA) (vessel area, VA)
and was identified as the edge between hypoechoic media
and hyperechoic adventitia. Lumen area (LA) was mea-
sured by tracing the leading edge of the intima before
stenting and of stent after intervention. Plaque plus media
CSA was accepted as a surrogate for plaque area (PLA)
because by IVUS was not possible to separate media from
plaque. Each of these parameters and both references
(proximal and distal) were analyzed in single slices. Plaque
burden (PB) was calculated according to the formula:
(VA - LA)/VA. The reference segments were the least
disease IVUS CSA (largest lumen with smallest pla-
que ? media) B 2–3 mm distal and proximal to the
stented segment [7]. EEM, lumen and plaque through the
entire lesion (stent ? 2–3 mm from the stent‘s edge) were
measured at 1 mm intervals. Overall, EEM, lumen and
plaque volume were calculated based on the Simpson’s
rule.
IVUS was performed in all cases in the parent vessel
(main vessel ? main branch) before and after stenting. The
following IVUS measurements were performed within the
bifurcation anatomy during analysis:
• Minimal lumen area (MLA), VA and corresponding
PLA at the lesion site (main vessel or main branch);
• MLA, VA and PLA at the level of the proximal rim of
the side branch ostium (also named proximal limb);
• MLA, VA and PLA at the level of distal rim of the side
branch ostium (also named distal limb);
• Window length, defined as the largest diameter between
carina and vessel wall (or between stent struts) at the
level of side branch inflow as seen from the main vessel;
• Window, defined as the CSA of the segment between
proximal and distal limb at the level of side branch
inflow
• MLA, VA and PLA measured at the level of the most
diseased segment within the window length (in-bifur-
cation segment);
• Plaque volume (PV) at baseline, defined as the
volumetric reconstruction of the lesion located between
proximal and distal references;
• Volumetric analysis:
• Plaque Volume (PV) at the bifurcation, defined as
the PV of vessel segment along the in-bifurcation
segment including CSAs at proximal limb, window
length and distal limb;
• PB at the bifurcation, defined as the vessel segment
along the in-bifurcation segment including CSAs of
proximal limb, window length and distal limb.
• The magnitude of changes in CSA in % at regions
of interest was determined by the following for-
mula: [(CSA at preprocedure—CSA at postproce-
dure)/CSA at preprocedure] 9 100.
Figure 1 illustrates sites for quantitative IVUS mea-
surements. Off-line quantitative IVUS analysis was per-
formed by two independent investigators (A. M, J. B),
unaware of the QCA measurements.
Statistical analysis
Continuous variables are presented as means ± one stan-
dard deviation. Categorical variables are expressed as
percentages. The differences between groups were exam-
ined with paired or unpaired t-tests as appropriate, with
normal distributions. Comparison among groups for cate-
gorical variables was made with the Chi square method.
All statistical analyses were performed using SPSS version
Int J Cardiovasc Imaging (2013) 29:1667–1676 1669
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13.0 for Windows (SPSS Inc., Chicago, Illinois). A p value
\0.05 was considered significant.
Results
There were 32 patients (75 % male) with stable coronary
artery disease enrolled. Overall, most baseline character-
istics did not differ among groups apart from diabetes,
which was significantly more frequent in the BiOSS group,
and smoking, which on the contrary, was more frequent in
the DES group. Only in the BiOSS group (8 cases), an
unprotected left main was the target vessel. The left ante-
rior descending artery was dominantly affected in the DES
group (81.3 %) versus 25 % in the BiOSS group (25 %). In
addition, there were no significant differences in regard to
bifurcation types according to the Medina classification.
Table 1 depicts baseline clinical and angiographic
characteristics.
Procedural and QCA results
Procedural data is shown in Table 2. During procedure,
patients enrolled in the DES group were treated with the
following stents: Luc-Chopin2 (Balton, Warsaw, Poland) in
8 cases, Promus (Boston Scientific, Natick, MA, USA) in 4
cases, and Xience V (Abbott Vascular, Santa Clara, CA,
USA) in 4 cases. As for the BiOSS group, the BiOSS
dedicated device was successfully implanted in all cases.
The main branch was predilated in the majority of cases in
both groups ([80 %) and final kissing balloon inflation was
62.5 % in DES versus 50 % in BiOSS groups. Device
success rate was 100 %, but there was the necessity to
implant an additional stent only in 1 patient in the BiOSS
group due to the significant side branch dissection after
predilatation. QCA data is presented in the Table 3. A
postprocedure, side branch ostial residual stenosis was
46 % in the DES group versus 32 % in the BiOSS group
(p \ 0.04). Moreover, the alpha (a) angle was significantly
higher in the BiOSS group (probably to the high contri-
bution at the left main lesions).
IVUS results
Plaque characteristics analysis showed even distribution for
individual plaque types including soft, hard and mixed
types in 23.5, 32.4 and 44.1 % in DES versus 28.9, 36.8
and 34.2 % in BiOSS, respectively. Similarly, no signifi-
cant differences were found regarding lesion length (as
Fig. 1 Schematic illustration of the bifurcation anatomy highlighting
the regions of interest assessed by IVUS analysis. MLA minimum
lumen area
Table 1 Baseline clinical and angiographic characteristics
Variable Group 1 (DES) Group 2 (BiOSS)
n 16 16
Age, years 64 ± 11 70 ± 9
Male gender, n (%) 11 (70.8) 13 (81.3)
Diabetes, n (%) 3 (18.8) 6 (37.5)*
Hypertension, n (%) 14 (87.5) 12 (75.0)
Dyslipidemia, n (%) 6 (37.5) 4 (25.0)
Smoking history, n (%) 6 (37.5) 1 (6.3)*
Previous MI, n (%) 7 (43.8) 7 (43.8)
Previous PCI, n (%) 10 (62.5) 10 (62.5)
Previous CABG, n (%) 0 1 (6.3)
Clinical presentation, n (%)
Stable angina 16 (100.0) 16 (100.0)
Target vessel, n (%)
LAD 13 (81.3) 4 (25.0)*
LCx 2 (12.5) 4 (25.0)
RCA 1 (6.3) 0 (0.0)
LM 0 (0.0) 8 (50.0)*
Medina classification, n (%)
1,1,1 6 (37.5) 8 (50.0)
0,1,1 2 (12.5) 3 (18.8)
1,0,1 3 (18.8) 3 (18.8)
1,1,0 4 (25.0) 2 (12.5)
1,0,0 1 (6.3) 0 (0.0)
0,1,0 0 (0.0) 0 (0.0)
0,0,1 0 (0.0) 0 (0.0)
Values are presented as mean ± standard deviation or frequencies
(percent of the total)
CABG coronary artery bypass graft surgery, LAD left anterior
descending, LCx left circumflex, LMS left main (unprotected), MI
myocardial infarction, PCI percutaneous coronary intervention, RCA
right coronary artery
* p \ 0.05 compared to DES group
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assessed by IVUS) and other quantitative parameters at
both proximal and distal references. Pre- and postproce-
dural measurements are presented in the Table 4. It is
important to underline that, excluding preprocedural PLA
for proximal limb (p = 0.05), the parameters before
stenting did not differ significantly between both groups.
Overall, the successful stent implantation caused signifi-
cant increase in LA at the target stenosis (MLA site),
proximal limb, distal limb and window within each group,
but they did not differ significantly between them, i.e., DES
versus BiOSS, Table 4. Actually, the only significant dif-
ference between DES versus BiOSS after intervention was
found for window length, which was significantly longer in
the group where the BiOSS stent was implanted
(p = 0.01). MLA at the level of the length was only
slightly bigger in the group where regular DES was
implanted, Fig. 2. Also, PV of the entire lesion and at the
level of the bifurcation after stenting decreased in both
groups; however, these changes were not statistically sig-
nificant. On the contrary, PB changes were statistically
significant; though they were not significant between both
groups (Fig. 3). In general, LA significantly increased at all
sites in both groups, but an increase in VA was found
significant only at the window level in the DES group. As
for PLA, there was a trend towards increasing at window at
the window with DES. A schematic illustration of % CSA
variation at regions of interest is shown in Fig. 4. Lastly,
measurements of vessel, lumen and plaque CSA before and
after stenting create an opportunity to identify mechanisms
of the lumen enlargement at regions of interest. Overall, 2
mechanisms appeared to contribute to poststenting lumen
increase, including vessel extension (stretch) and plaque re-
distribution, Table 5.
Discussion
The increasing experience in percutaneous coronary inter-
ventions, the continuous improvement of technical
parameters of angioplasty materials and encouraging
results obtained with new DES generations cause a broader
selection of coronary stenoses and opening for lesions,
which were considered not long ago as uninviting for
percutaneous coronary interventions [8]. Undoubtedly,
lesions located at coronary bifurcations are a great example
of such stenoses and their rate is systematically increasing
among catheterized patients [9].
It has been proven that DES based on the classical
construction, where basic elements are the same along a
stent, are biased by many limitations. The most important
is maximal cell‘s size [10, 11]. As a result that construction
particularly in case of not optimal stent implantation may
predispose not only to periprocedural complications like
side branch closure, intra-stent thrombosis, but also to
long-term complications, such as restenosis and late or very
late stent thrombosis [12, 13]. These facts are good reasons
to search for a stent a‘priori designed for a coronary
bifurcation (DBS–dedicated bifurcation stent). There are
many publications regarding those devices and their num-
ber systematically increases [14–18]. Among four DBS‘s
types, the most favored seems to be this designed for the
parent vessel treatment and simultaneous protection and
access to the side branch [19], given that the ESC guide-
lines strongly recommends provisional side branch stenting
taking into consideration not only immediate but also long-
term results of this strategy [8].
The BiOSS stent belongs to the above mentioned type of
DBS. Its construction have rose the question on whether
1.2 mm long intermediate zone of that stent appears as the
Table 2 Procedural data
Variable DES BiOSS
n 16 16
Vascular access, n (%)
Femoral 2 (12.5) 4 (25.0)
Radial 14 (87.5) 12 (75.0)
Guiding-catheter size, n (%)
6-Fr. 16 (100.0) 4 (25.0)*
7-Fr. 0 (0.0) 12 (75.0)*
Predilatation, n (%)
MV ? MB 13 (81.3) 14 (87.5)
SB 9 (56.3) 12 (75.0)
Both branches 7 (43.8) 9 (56.3)
Study stent implanteda 16 (100.0) 16 (100.0)
Nominal stent length, mm 18.94 ± 6.14 16.13 ± 1.5
Nomimal stent diameter, mm
MV 3.41 ± 0.36 3.66 ± 0.27
MB – 3.01 ± 0.18
Additional stent implanted, n (%)
MV ? MB 0 (0.0) 0 (0.0)
SB 0 (0.0) 1 (6.3)
Balloon postdilatation, n (%)
MV ? MB (Bottle balloon) 0 (0.0) 3 (18.8)
SB 12 (75.0) 7 (43.8)
Final KBI 10 (62.5) 8 (50.0)
Contrast volume, ml 195 ± 71 171 ± 38
Fluoroscopic time, min 14.2 ± 6.4 17.5 ± 8.5
Procedural time, min 83 ± 27 74 ± 25
Values are presented as frequencies (percent of the total) or
mean ± standard deviation
KBI kissing-balloon inflation, MB main branch, MV main vessel, SB
side branch
* p \ 0.05 versus DES group
a According to randomization
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Table 3 Baseline and final QCA
Variable DES (n = 16) BiOSS (n = 16) p value
Pre (a) Post (b) Pre (c) Post (d) Pre (a vs. c) Post (b vs. d)
Lesion length, mm
MV ? MB 17.9 ± 4.0 – 15.3 ± 5.0 – 0.06 –
MB only 9.8 ± 7.9 – 6.0 ± 4.2 – 0.10 –
SB 5.0 ± 4.4 – 4.9 ± 6.4 – 0.97 –
RVD, mm
MV 3.4 ± 0.4 3.4 ± 0.4 3.4 ± 0.4 3.5 ± 0.4 0.67 0.29
MB 2.7 ± 0.5 2.8 ± 0.5 2.9 ± 0.5 2.8 ± 0.3 0.39 0.84
SB 2.2 ± 0.4 2.2 ± 0.5 2.4 ± 0.6 2.4 ± 0.5 0.18 0.25
% DS
MV 51 ± 18 3 ± 10 52 ± 19 8 ± 12 0.88 0.26
MB 50 ± 18 2 ± 19 52 ± 16 3 ± 11 0.74 0.77
SB 46 ± 11 46 ± 17 38 ± 15 32 ± 20 0.09 0.04
a angle, degress 42.0 ± 13.5 40.4 ± 8.8 52.1 ± 22.0 53.5 ± 20.0 0.15 0.04
Values are presented as mean ± standard deviation
DS diameter stenosis, MB main branch, MV main vessel, RVD reference vessel diameter, SB side branch
Table 4 Baseline and final IVUS measurements comparing DES versus BiOSS groups
Variable DES BiOSS p value
Pre (a) Post (b) Pre (c) Post (d) Pre (a vs. c) Post (b vs. d)
MLA site
LA, mm2 2.87 ± 0.78 6.08 ± 2.01 2.99 ± 0.82 6.49 ± 2.2 0.68 0.68
VA, mm2 14.79 ± 4.75 16.43 ± 4.95 17.37 ± 7.57 18.04 ± 8.03 0.26 0.5
PLA, mm2 11.88 ± 4.47 9.63 ± 3.71 14.37 ± 7.02 11.54 ± 6.25 0.24 0.3
PL site
LA, mm2 4.78 ± 1.49 7.86 ± 2.08 3.89 ± 0.98 7.84 ± 1.99 0.06 0.97
VA, mm2 16.36 ± 3.77 18.01 ± 5.16 19.23 ± 6.79 20.91 ± 8.24 0.15 0.24
PLA, mm2 11.59 ± 3.79 10.47 ± 4.02 15.35 ± 6.48 13.08 ± 6.99 0.05 0.21
DL site
LA, mm2 5.21 ± 3.18 7.46 ± 2.2 4.78 ± 2.18 6.44 ± 1.85 0.66 0.17
VA, mm2 14.25 ± 5.38 16.59 ± 4.61 13.2 ± 4.22 14.53 ± 4.86 0.54 0.23
PLA, mm2 9.06 ± 3.4 9.09 ± 3.71 8.45 ± 2.59 8.09 ± 3.67 0.57 0.45
Window area
Window length, mm 2.31 ± 0.38 1.76 ± 0.52 2.09 ± 0.50 2.21 ± 0.37 0.79 0.01
LA, mm2 4.86 ± 2.44 7.63 ± 2.03 3.99 ± 1.19 6.52 ± 1.64 0.21 0.1
VA, mm2 13.89 ± 2.59 17.56 ± 5.22 13.71 ± 3.98 14.88 ± 4.31 0.88 0.12
PLA, mm2 9.06 ± 2.27 9.94 ± 4.32 9.72 ± 3.91 8.36 ± 3.99 0.56 0.29
Volumetric analysis
PV, mm3 174.44 ± 49.88 153.13 ± 36.46 164.43 ± 62.35 149.42 ± 68.01 0.64 0.86
PB, % 64.2 ± 4.6 50.9 ± 4.6 60.8 ± 9.1 50.5 ± 7.9 0.21 0.86
PV at in-bifurcation segment, mm3 42.9 ± 14.09 35.53 ± 6.67 47.41 ± 19.35 40.35 ± 15.87 0.48 0.30
PB at in-bifurcation segment, % 66.5 ± 9.3 53.9 ± 8.8 72.1 ± 6.9 55.2 ± 9.2 0.07 0.71
Values are presented as mean ± standard deviation
DL distal limb, LA lumen area, MLA minimum lumen area, PB plaque burden, PL proximal limb, PLA plaque area, PV plaque volume, VA vessel
area
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weakest part predisposing to restenosis and intra-stent
thrombosis. Recently published 3-month results [1] and
already known 12-months results [20] of BiOSS Expert
Registry deny those assumptions. However, we decided to
assess whether the implantation of the BiOSS stent impacts
mechanisms involved in lumen enlargement and conse-
quently, side branch compromise, in comparison with
classical provisional T-stenting strategy with DES. The
results of the QCA analysis performed in the studied
population were not surprising, bearing in mind the well-
known weakness of this method [9]. Our data unequivo-
cally indicate that final results achieved in both groups
(MLD, diameter stenosis) did not differ significantly.
However, it deserves to note that in the group where the
BiOSS stent was used, final diameter stenosis at side
branch significantly decreased on the contrary to the other
group. This finding was confirmed in 12 months analysis of
BiOSS Expert Registry as well [20]. IVUS was chosen as
the tool for the comparative assessment. It is known that
this invasive diagnostic method gives opportunity not only
to analyze the enlargement of the vessel and lumen, but
also changes in vessel and atherosclerotic plaque areas [9].
According to the assumption, more definitive information
was obtained by the analysis of IVUS recordings. It must
be underlined that qualitative and quantitative analyses did
not show significant preprocedural differences between
both groups. The analysis of classical quantitative ultra-
sonic parameters allowed to ascertain that both classic DES
as well as BiOSS stenting enable to obtain the comparable
increase of lumen in most stenosed parent vessels (main
vessel ? main branch). Simultaneously, the BiOSS stent
construction (of course in case of proper implantation)
provides a better access to side branch in comparison to the
classic DES. It was proven by significantly bigger window
length in the BiOSS group—a parameter which represents
the access to the side branch.
It is known from the literature that the mechanism of the
stent expansion is a combination of the vessel stretch and
the plaque ‘‘reduction’’ [21, 22]. However, more detailed
studies analysis have shown that the last mechanism is
more complex [23, 24]. It consists of the axial redistribu-
tion of atheromatous plaque [25, 26] and plaque com-
pression [23] rather than embolization [27]. Previous IVUS
studies have demonstrated that in non-calcific lesions, the
mechanisms of the lumen enlargement after stenting (direct
implantation or after predilatation) are significantly influ-
enced by atherosclerotic remodeling, plaque eccentricity
and plaque composition [21]. Birgelen et al. showed that a
Fig. 2 Changes in window
length (a) and lumen CSA at
window (b) comparing pre-
versus postprocedure
measurements within each
group. *p \ 0.05. CSA cross-
sectional area
Fig. 3 IVUS volumetric
analysis comparing pre- and
postprocedure measurements
within each group showing
changes in PV (left) and PB
(right) at in-bifurcation segment
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proper remodeling pattern of coronary lesions has signifi-
cant impact on mechanisms of lumen enlargement during
stent deployment. Lesions with positive remodeling
showed more plaque extrusion into distal reference and less
stent-induced vessel stretch than those with negative
remodeling [22]. They also found that marked plaque
extrusion occurs only in lesions with calcium arc \120
within the vessel circumference. In both groups, vessel and
lumen areas increased equally, while the plaque area
decreased after stent deployment [24]. Algowhary et al.
[25] showed axial redistribution of atheromatous plaque
along the segment and proximal and distal reference seg-
ments. Prati et al. [27] found that the decrease in the plaque
area during stenting predicts CK-MB release suggesting a
high association between stenting and plaque embolization
in patients with unstable angina pectoris. Also, Maehara
et al. [26] found that plaque re-distribution, not compres-
sion, as a result of stent expansion translates disease
accumulation from the mid-stent zone to the distal stent
zone, given that after balloon postdilatation, the additional
lumen gain is proportional to more plaque redistribution
rather than vessel expansion. According to Dudek et al.
[23] stenting causes vessel expansion to accommodate the
plaque mass pressed by the stent and longitudinal plaque
redistribution along the stented segment with plaque
shifting to the proximal and distal reference segments.
Nonetheless, there are some differences between cited
above papers and our work. Firstly, we studied bifurcation
lesions in patients with stable coronary artery disease and
secondly, we decided to perform comparative analysis of
Fig. 4 Lumen, vessel and
plaque CSA variations (%) at
regions of interest










Vessel extension DES 54 130 98 51
BiOSS 43 46 80 19
Plaque re-distribution DES 36 -30 2 49
BiOSS 57 54 20 81
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two stents different in design. The fact that there were not
significant differences in terms of preprocedural IVUS
parameters (qualitative and quantitative) increases reli-
ability of the above mentioned analysis. It is worthy to be
stressed that precise analysis of changes in vessel, lumen
and plaque areas along the lesion to be stented in key
places (proximal and distal limbs, target stenosis, window
length) of bifurcation allows to define in detail the influ-
ence of the BiOSS construction on mechanisms of lumen
enlargement. To our knowledge this is first paper on
mechanisms of lumen enlargement after coronary stenting
of bifurcation lesions. It is very interesting that we did not
find uniform operating mechanisms not only between two
compared stents but also within both groups taking into
account measurements along the lesion. And so, in the
BiOSS group at the level of target stenosis, the greater
degree of lumen enlargement was achieved due to plaque
‘‘reduction’’ versus vessel expansion (81 vs. 19 %). On the
contrary, in the DES group, those two mechanisms played
a similar role (50 vs. 50 %). Completely different relations
were found at the level of distal limb where vessel
expansion was the superior mechanism over plaque
reduction (80 vs. 20 % in BiOSS; 98 vs. 2 % in DES;
respectively). This small PLA decrease at the level of distal
limb in the DES group seems to be in association with axial
plaque redistribution, especially that in the adjacent site—
window region. In the same group (DES), we found PLA
increase in the contrary to the BiOSS group, where two
mechanisms were quite well balanced (43 % vessel
expansion vs. 57 % plaque reduction). Those findings
confirm that the construction of the classical stent does not
take into consideration vessel tapering in bifurcation
lesions and results in carina and plaque shift—the main
mechanisms of side branch compromise. Furthermore, the
analysis of plaque, lumen and vessel areas at the level of
proximal limb showed that the mechanisms were similar in
both groups. However, a trend to a bigger vessel lumen
increase with simultaneous plaque ‘‘reduction’’ at the site
of proximal limb in the BiOSS group confirmed that the
construction of that stent assures the realization of the
proximal optimization technique (POT) which is strongly
recommended by European Bifurcation Club [28]. If add
proofs for smaller changes in vessel and lumen areas at the
level of the distal limb after BiOSS stent implantation and,
not surprisingly, smaller residual stenosis at side branch
ostium in the group where that stent was used. These
findings confirm, in an indirect manner, that the BiOSS
stent construction limits carina and plaque shift towards
side branch, which are two major factors responsible for
side branch compromise. As a consequence, such design
affects less the in-bifurcation segment; this is expressed by
significantly smaller VA increase, negligible differences in
LA increase and PLA reduction. These observations prove
that construction of the BiOSS stent enables more physi-
ological fitting for the bifurcation anatomy. Moreover, it
allows to believe that the principle of ‘‘less injury, less
vessel response (less neointimal proliferation)’’ may
translate into very good clinical results [29, 30]. Also, it
must be stressed that postprocedure analysis revealed that
there was main branch stent oversizing in DES group, but
not in BIOSS group, and this might be an additional factor
responsible for the final results of our study.
Finally, analysis of PV changes, which were equal for
entire lesion as well as for bifurcation specific segments,
proves that the implantation of both types of stents leads to
its insignificant reduction (Table 4). However, it should be
stressed that PB parameter, obtained by volumetric analysis
of residual plaque area in relation to VA within the seg-
ment of interest, underwent significant reduction in both
studied groups. The value of this parameter, which was
around 50 % plus the presence of a potent antiproliferative
drug, seems to be an additional argument for at least
similar long-term results for classic DES versus BiOSS
stents [31].
Conclusions
Our results suggest different mechanisms of lumen
enlargement in coronary bifurcation lesions treated by
percutaneous coronary interventions with provisional
approach with conventional DES versus the BiOSS DBS.
Overall, there comparable luminal gain, but the BiOSS
stent was associated with less luminal compromise and
plaque re-distribution at the level of the side-branch in-flow
at the in-bifurcation segment.
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